Caeregen Therapeutics develops therapies which repair, restore, and protect damaged and diseased tissues by reactivating the pathways and signaling which accompany normal cellular and tissue development. Caeregen is developing Noregen, a recombinant protein mimetic of human norrin-derived growth factor for the potential treatment of retinal-related vision loss.
Company Location
510 Meadowmont Village Circle, Suite 303
Chapel Hill
NC
27517
Phone
(203) 278-1172
County
Region
Company Details
Company type
Employment range in NC
US headquarters
Michigan
Global headquarters
United States
Primary site activity
All company activities
Products under development
Noregen